APA (7th ed.) Citation

Tessoulin, B., Bouabdallah, K., Burroni, B., Lamy, T., Gressin, R., Cartron, G., . . . Le Gouill, S. (2020). Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA. Annals of Hematology, 99(8), 1771. https://doi.org/10.1007/s00277-020-04159-3

Chicago Style (17th ed.) Citation

Tessoulin, Benoît, et al. "Safety and Efficacy of Temsirolimus in Combination with Three Different Immuno-chemotherapy Regimens in Relapse and Refractory Mantle Cell Lymphoma, Final Results of the T3 Phase IB Trial of the LYSA." Annals of Hematology 99, no. 8 (2020): 1771. https://doi.org/10.1007/s00277-020-04159-3.

MLA (9th ed.) Citation

Tessoulin, Benoît, et al. "Safety and Efficacy of Temsirolimus in Combination with Three Different Immuno-chemotherapy Regimens in Relapse and Refractory Mantle Cell Lymphoma, Final Results of the T3 Phase IB Trial of the LYSA." Annals of Hematology, vol. 99, no. 8, 2020, p. 1771, https://doi.org/10.1007/s00277-020-04159-3.